Phenylthiourea Specifically Reduces Zebrafish Eye Size by Li, Zeran et al.
Phenylthiourea Specifically Reduces Zebrafish Eye Size
Zeran Li
1,2, Devon Ptak
1, Liyun Zhang
1, Elwood K. Walls
1,3, Wenxuan Zhong
4, Yuk Fai Leung
1,5*
1Department of Biological Sciences, Purdue University, West Lafayette, Indiana, United States of America, 2Division of Biology & Biomedical Sciences, Washington
University in St. Louis, St. Louis, Missouri, United States of America, 3Department of Cellular and Integrative Physiology, Indiana University School of Medicine Lafayette,
West Lafayette, Indiana, United States of America, 4Department of Statistics, University of Illinois at Urbana-Champaign, Champaign, Illinois, United States of America,
5Department of Biochemistry and Molecular Biology, Indiana University School of Medicine Lafayette, West Lafayette, Indiana, United States of America
Abstract
Phenylthiourea (PTU) is commonly used for inhibiting melanization of zebrafish embryos. In this study, the standard
treatment with 0.2 mM PTU was demonstrated to specifically reduce eye size in larval fish starting at three days post-
fertilization. This effect is likely the result of a reduction in retinal and lens size of PTU-treated eyes and is not related to
melanization inhibition. This is because the eye size of tyr, a genetic mutant of tyrosinase whose activity is inhibited in PTU
treatment, was not reduced. As PTU contains a thiocarbamide group which is presented in many goitrogens, suppressing
thyroid hormone production is a possible mechanism by which PTU treatment may reduce eye size. Despite the fact that
thyroxine level was found to be reduced in PTU-treated larvae, thyroid hormone supplements did not rescue the eye size
reduction. Instead, treating embryos with six goitrogens, including inhibitors of thyroid peroxidase (TPO) and sodium-iodide
symporter (NIS), suggested an alternative possibility. Specifically, three TPO inhibitors, including those that do not possess
thiocarbamide, specifically reduced eye size; whereas none of the NIS inhibitors could elicit this effect. These observations
indicate that TPO inhibition rather than a general suppression of thyroid hormone synthesis is likely the underlying cause of
PTU-induced eye size reduction. Furthermore, the tissue-specific effect of PTU treatment might be mediated by an eye-
specific TPO expression. Compared with treatment with other tyrosinase inhibitors or bleaching to remove melanization,
PTU treatment remains the most effective approach. Thus, one should use caution when interpreting results that are
obtained from PTU-treated embryos.
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Introduction
Phenylthiourea (PTU) has long been demonstrated to inhibit
melanization, the formation of black pigment, in various animals.
Inhibition of melanization by PTU has been observed in rats [1,2],
ascidians [3,4,5], planarians [6], moths [7], frogs [8,9,10],
salamanders [11], tropical fish [12] and zebrafish [13]. Specifi-
cally, PTU inhibits tyrosinase, a key enzyme in the melanogenic
pathway [14], by binding to copper ions and by interacting with
the side chains in the active site [15]. This pigment inhibition
effect of PTU is reversible; once PTU is removed from the system,
melanization will resume [1,5].
In recent years, zebrafish (Danio rerio) has become a popular
research model [16]. The relative transparency of zebrafish
embryos compared with the other vertebrate models and its ex
vivo mode of development can facilitate the visualization and
imaging of the developmental process. In particular, melanization
of zebrafish embryos can be conveniently inhibited by treating
embryos with 0.003% (w/v) or 0.2 mM PTU (commonly referred
to as 1X PTU) starting from about 12 hours postfertilization (hpf)
to shortly before 24 hpf [17,18,19,20,21,22]. It has also been
reported that treating embryos with 0.075 mM or 0.375X PTU at
about 24 hpf can inhibit melanization [23]. However, this
approach is not very effective and embryos always contain
considerable melanization after treatment [24]. Another way of
suppressing melanization is by utilizing genetic mutants of
pigmentation [25], including sandy/tyr [21], nacre [26] and casper
(double mutant of nacre and roy, an iridophore mutant) [27].
Nonetheless, using mutant embryos is not as versatile as PTU
treatment for many downstream investigations. Thus, PTU
treatment remains the prime choice for inhibition of melanization.
Despite the convenience of PTU treatment in inhibiting
melanization, it has been shown in several animal models that
this treatment can produce undesirable side effects at the
molecular and physiological levels. For example, it has been
shown that PTU treatment perturbs gene expression in zebrafish
embryos. These include an activation of cytochrome P4501A1
(cyp1a1) [28] and a suppression of retinol-binding protein 4 (rbp4)
[29]. In ascidians, it has been demonstrated that treatment with
0.35 – 0.5 mM PTU slightly shortens the length and causes a
curvature in the tails [5]. In addition, two other studies have
reported that a lower concentration of PTU treatment at 0.001%
prevents normal elongation of the notochord [3], and also causes
short curved tails, immobility and a suppression of metamorphosis
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PTU through feeding and/or intraperitoneal injection can cause
both acute and chronic toxicity [30]. Interestingly, the studies on
rats have also led to the original discovery of thyroid hypertrophy
and in turn the goitrogenic effect of PTU [31,32], which has been
subsequently confirmed in studies of the frog [8]. In zebrafish, it
has been shown that treating zebrafish larvae with 0.003% PTU
can suppress thyroid hormone (T4) immuno-reactivity in thyroid
follicles [33]. A recent report by Bohnsack and colleagues showed
that PTU treatment can alter retinoic acid and insulin-like growth
factor regulation of neural crest and craniofacial development in
zebrafish [34]. The authors also found that this PTU-induced
problem is partially rescued by thyroid hormone supplement.
However, it has also been demonstrated that the developmental
abnormalities in ascidians caused by PTU treatment are not
primarily due to anti-thyroid effect or pigment inhibition [3,4].
Thus, PTU can potentially exert its effect on embryonic
development through a variety of molecular mechanisms.
In our own studies, we have noticed a possible reduction of eye
size of zebrafish larvae after treatment with 1X PTU (Figure 1A).
Several factors have been tested as the potential cause of this
phenotype, including the batch and supplier of PTU, the starting
time of PTU treatment (12 vs. 24 hpf), the specific experimenter
(at least four researchers prepared the chemicals and treated
embryos independently over the course of the project) and
laboratory locations (the experiments have been conducted at
two different locations). None of these factors appear to be
associated with the eye size reduction, suggesting that it may be a
specific effect of PTU treatment. In fact, such an effect on eye size
reduction has been documented in frogs [8,35], but has not been
further studied. The current study describes the characterization of
the effect of PTU treatment on eye development in zebrafish. In
particular, the results provide experimental evidence that the
PTU-induced effect on eye size reduction is not caused by a
general inhibition of thyroid hormone production or melanization,
but is likely mediated through a more specific inhibition of a
thyroid peroxidase (TPO) or TPO-like activity in zebrafish
embryos.
Results
PTU treatment specifically reduces eye size in zebrafish
To quantify the specific reduction of eye size, eye and body size
of larvae treated with 1X PTU (PTU) and untreated siblings
(control) were measured. Two types of parameters were used for
measuring size, including anterior-posterior length and area. For
each type of parameter, a ratio between the eye and body
measurements was calculated (eye/body size ratio), which is
essentially a normalized eye measurement. This ratio was used in
subsequent analyses for eye-specific size change. Twenty-two
independent experiments were conducted at three days postfertil-
ization (dpf), with at least 10 embryos in each treatment group per
experiment (total N =343 for each group). Length and area
measurements were used in 18 and 4 experiments respectively. To
compare the eye and body measurements and the eye/body size
ratios between the control and PTU-treated groups in each
experiment, Wilcoxon rank sum tests were conducted and the
resulting p-values of the same type of measurements were adjusted
for multiple hypothesis testing. The adjusted p-values are
presented in a heatmap, in which the color of an individual box
also represents the nature of the difference (Figure 1B; green: PTU
, Control, p-value ,0.001; dark green: PTU , Control, p-value
.0.001 & ,0.05; black: no change, p-value .0.05). Several
patterns have been observed: first, there were more experiments
(18/22 (81.8%)) in which the eye measurements were reduced by
PTU treatment (p,0.05), compared with only 2/22 (9.1%) of the
experiments in which the body measurements were reduced;
second, the two experiments that had a reduction in body
measurements had a concomitant reduction in eye measurements
(p,0.05), but not vice versa. The p-value of the eye measurement
reduction is at least equal to if not smaller than the body
measurement reduction in both cases; third, there was a specific
reduction of eye measurements relative to body measurements in
13/22 (59.1%) of the experiments, as determined by the eye/body
size ratio. To evaluate the extent of this specific reduction,
measurements from these 22 experiments were combined and
analyzed by linear mixed-effects model. The effect on eye/body
size ratio caused by PTU treatment was modeled as a fixed effect,
while the experiments done on different days were modeled as a
random effect. A separate model was fitted for the length and area
measurements respectively. The analyses show that PTU treat-
ment had a specific effect on the eye/body size ratio, regardless of
the measurement type (length measurements: F(1, 521) =148.67,
area measurements: F(1, 141) =24.97, p-value ,0.001 in both
cases). Specifically, the eye/body size ratios of the PTU-treated
larvae were smaller than the control larvae (length measurements:
97.25% of controls, standard error (SE) =2.10%; area measure-
ments: 96.52%, SE =2.05%; p-values =2.93e–30 and 1.70e–06
respectively). Together, these data indicate that PTU treatment
preferentially reduces eye measurements compared with the whole
body measurements. Length measurements were used in subse-
quent analysis unless specified otherwise.
To further quantify the effect of PTU treatment on eye size
during embryogenesis, the eye and body length measurements of
PTU-treated and control larvae (N=15 for each group) were
collected starting from 2 dpf for several days. Ten independent
experiments were conducted and the results of one of these
developmental series are shown in Figure 1C. By 3 dpf, the eye/
body size ratios of the PTU-treated larvae were already
measurably smaller (Wilcoxon rank sum test, Holm-adjusted p-
value ,0.05) in 6 out of 9 or 66.67% of the experiments that were
conducted at 3 dpf. This is similar to the 59.1% frequency of
occurrence as observed in the 3 dpf measurements as described in
Figure 1B above. By 4 dpf, the eye/body size ratios of the PTU-
treated larvae in 6 out of 9 or 66.67% of the measured
experiments were smaller (p-value ,0.05). While at 5 dpf, 3 out
of 6 or 50% of the measured experiments still showed a size
difference (p-value ,0.05). Measurement of larvae older than 5
dpf was not conducted because this is the approximate stage when
feeding usually begins [36]; and the behavioral variation in food
consumption can be a confounding factor for morphological
measurement. Nonetheless, a smaller eye/body size ratio in PTU-
treated larvae between 3–5 dpf indicates that the observed
reduction in eye size is not likely to be an overall developmental
delay but rather a specific effect on eye development imposed by
PTU treatment.
PTU treatment reduces retinal and lens size but not
retinal cell number
To investigate whether PTU treatment would alter retinal cell
number, five plastic sections of PTU-treated and control larvae
were collected and analyzed at 4 dpf (Figure 2). The number of
cells in dorsal and ventral retina, defined as cells found dorsal or
ventral to the optic nerve, was counted from both eyes. The
categories that were counted include GCs, HCs, photoreceptors,
cells in the proliferative marginal zone and cells in the inner
nuclear layer with and without HCs. The retinal and lens areas
were also measured from these samples. A linear mixed-effects
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between PTU-treated and control larvae with individual larva
modeled as a random effect. There were no differences in any cell
counts between these two groups (p-value .0.05 in all cases).
However, the dorsal retinal areas were smaller in the PTU-treated
group (mean ( x x)=11870 mm
2, standard deviation (s)=564 mm
2)
compared with the control group ( x x=13560 mm
2, s=1138 mm
2)
(F(1,8) =8.83, p-value =0.018); whilethe ventralretinalareas were
not different between the two groups (PTU-treated:  x x=6701 mm
2,
s=530 mm
2; control:  x x=7103 mm
2, s=751 mm
2; F(1, 8) =0.96, p-
value =0.36). This resulted in the whole PTU-treated retinas being
marginally smaller than the controls (PTU-treated:  x x=18570 mm
2,
s=1066 mm
2; control:  x x=20660 mm
2, s=1853 mm
2; F(1, 8)
=4.78, p-value =0.06). Further, the lens were also smaller in the
PTU-treatedgroup( x x=5729 mm
2,s=968mm
2)comparedwiththe
control group ( x x=7081 mm
2, s=593 mm
2)( F(1, 8) =6.85, p-value
=0.031). The cell density (cell count/retinal area) of the PTU-
treated larvae was marginally higher than the controls on the
dorsal (PTU-treated: ( x x)=0.037 mm
2, s=0.0011 mm
2; control:
 x x=0.034 mm
2, s=0.0024 mm
2; F(1, 8) =4.38, p-value =0.070)
and whole retina (PTU-treated:  x x=0.036 mm
2, s=0.0014 mm
2;
control:  x x=0.034 mm
2, s=0.0022 mm
2; F(1, 8) =4.39, p-value
=0.069). Additionally, cell density of ganglion cell layer (GCL),
inner nuclear layer (INL), outer nuclear layer (ONL), and marginal
zone were individually analyzed ondorsal,ventraland wholeretina,
but none of them showed any differences between PTU-treated and
control larvae (p-values .0.05). Together with the morphometric
measurements, the results indicate that the reduction in eye size
caused by PTU treatment is likely a result of a general reduction of
dorsal retinal and lens size.
Figure 1. PTU treatment specifically reduces eye size starting at 3 dpf. (A & A’) After PTU treatment (PTU), the production of black pigment
or melanization in a larva was suppressed (A’). In addition, the eye size of the PTU-treated larvae also appeared smaller compared with the untreated
siblings (control) (A) at 3 dpf. Scale bar =100 mm. (B & C) To quantify potential differences in eye size, the anterior-posterior length or area of eye and
body were measured in multiple experiments conducted on different days. (B) A heatmap that shows the results from 22 independent experiments at
3 dpf. At least 10 embryos were used in each treatment group per experiment. Each column represents one experiment and the individual box
represents the Holm-adjusted p-value of a Wilcoxon rank sum test for the comparison of eye or body measurements, or their ratios (eye/body size
ratios) between PTU-treated and control larvae. The color of each box represents the difference in the means of the parameter between the two
groups and the intensity represents the corresponding p-value of each test (green: PTU , control, p-value ,0.001; dark green: PTU , control, p-value
.0.001 & ,0.05; black: PTU = control, p-value .0.05). The experiments analyzed by area measurements are highlighted by asterisks; otherwise, they
were analyzed by length measurements. The PTU treatment specifically reduced the measurements of the eye size compared with the body size. See
text for further supporting statistical analyses. (C) A plot of the means of eye/body length ratios of 15 control and PTU-treated larvae at 2–5 dpf
obtained from one of the multi-days experiments. The error bars show the 95% confidence intervals.
doi:10.1371/journal.pone.0040132.g001
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and apoptosis of the retina
To further assess potential histological changes in the PTU-
treated eyes, immunostaining experiments were conducted on
cryosections at 4 dpf with immunohistochemical markers for
major cell types in retina, retinal pigment epithelium (RPE),
apoptosis and proliferation (Figure 3; N = at least 5 in each
condition). The positive signal area or cell count was normalized to
the corresponding retinal area for comparisons. First, there were
no changes in the normalized positive-signal area or the overall
pattern of the staining between the PTU-treated and control
larvae. This was true for all major retinal cell types, including
cones (anti-zpr1; Figure 3A & A’; Wilcoxon rank sum test, p-value
=0.22), rods (anti-zpr3; Figure 3C & C’; Wilcoxon rank sum test,
p-value =0.84), ganglion cells (GCs), amacrine cells (ACs), bipolar
cells (BCs) and horizontal cells (HCs) (anti-Islet-1; Figure 3D & D’;
Wilcoxon rank sum test, p-value =0.13). To analyze Mu ¨ller cells
(MCs), fluorescence signals in the retinas of Tg(gfap:GFP)
mi2001
transgenic larvae were compared [37]. Again, there was no
difference between the number of GFP+ cells per retinal area
between PTU-treated and control larvae (Figure 3F & F’)
(Wilcoxon rank sum test, p-value =0.34). These results suggest
that PTU treatment does not affect the differentiation of major
retinal cell types. Indeed, the failure of PTU treatment to influence
cellular differentiation in the retina was also confirmed by the lack
of a difference in the immunostaining result of the axons of
differentiated neurons (anti-acetylated a-tubulin; Figure 3E & E’)
(Wilcoxon rank sum test, p-value =0.42). Second, the only
difference between PTU-treated larvae compared with the
controls was an increase in the zpr2+ RPE signal per retinal area
(Figure 3B & B’; Wilcoxon rank sum test, p-value =0.0079). This
result is probably due to the formation of melanophores in the
wild-type (WT) RPE cells, which might have interfered with the
fluorescence emission. Third, there was no apparent change in the
proliferation status, as indicated by a comparable number of
mitotic cells between PTU-treated and control larvae (anti-PH3;
Figure 3G & G’) (Wilcoxon rank sum test, p-value =0.29). The
analyses of this marker at earlier developmental stages including
36, 48 and 60 hpf also did not show any difference (p-values
=0.71, 0.34 and 0.9 respectively). Fourth, the observation that
there was rarely any anti-active caspase3 staining in the retinas
(Figure 3H & H’) strongly suggests that PTU-treatment did not
induce apoptosis in the retinas. Thus, these experiments indicate
that PTU treatment did not alter differentiation, proliferation,
apoptosis or cell numbers of the retina. The effect of PTU
treatment on RPE staining was probably due to the inhibition of
melanization.
PTU’s effect on eye size reduction is not caused by
inhibition of melanization
Since PTU treatment suppresses melanization by inhibiting
tyrosinase, it is logical to hypothesize that the PTU effect on eye
size reduction may be mediated through alteration of the
pigmentation pathway. To test this hypothesis, eye and body
lengths of tyr
tk20/tk20, a genetic mutant of tyrosinase [25], were
measured. Tyr
tk20/tk20 mutants cannot form any black pigment and
have a similar morphology compared with the PTU-treated em-
bryos. Five independent experiments were conducted on tyr
tk20/tk20
and WT siblings with normal melanization, and a total of 70
larvae were measured in each condition at 3 dpf. The results from
a linear fixed-effects model analysis indicate that the genotype
of the larvae did not change the eye/body size ratio (F(1, 136)
=2.03, p-value =0.16). Subsequent measurements in two
experiments on older 4 dpf larvae (N=20 for each condition)
also showed that the genotype did not affect eye/body size ratio
when compared with WT siblings at the same stage (F(1, 37)
=2.03, p-value =0.09). Thus, the results indicate that altered
activity of tyrosinase and the resulting change in the levels of
downstream metabolites in the melanization pathway do not affect
eye size. The eye size reduction caused by PTU treatment is likely
due to an uncharacterized chemical property of PTU.
PTU treatment inhibits thyroid hormone production but
its specific effect on eye size reduction is not rescued by
thyroid hormone supplement
It has been reported that PTU treatment inhibits thyroid
hormone production [33], which can be the underlying cause of
eye size reduction. Indeed, whole-mount immunostaining against
Figure 2. Histological analysis of zebrafish eyes before and after PTU treatment. Histological analysis was conducted on 1-mm-thick plastic
sections of PTU-treated and control larvae at 4 dpf. The number of different recognizable cell types and categories was counted and the area of the
retinas measured. Five sections were analyzed per condition. There are no differences in the counts for all cell types and categories, but the dorsal
retinal and lens areas are smaller while the whole retinal area and cell density are marginally higher in the PTU-treated eyes. MZ: marginal zone, HC:
horizontal cells, GCL: ganglion cell layer, INL: inner nuclear layer, ONL: outer nuclear layer. The RPE is indicated by red arrows. Scale bar =50 mm.
doi:10.1371/journal.pone.0040132.g002
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dpf shows that the staining of T4+ thyroid follicles was
substantially reduced or absent in the PTU-treated group
(Figure 4A). Therefore, these observations suggest that reductions
in thyroid hormone levels by PTU treatment might play a role in
eye size reduction. To test this hypothesis, different thyroid
hormones were respectively added into the E3 medium with PTU
to rescue the eye size of PTU-treated larvae. These include 30 nM
T4, 10 nM triiodothyronine (T3), and 0.1 mM 3,39,5-triiodothyr-
oacetic acid (TriAc) [38], a thyroid hormone analogue.
The effectiveness of these three thyroid hormones was
determined by quantitative PCR (qPCR) of two reporter genes,
Figure 3. Immunohistochemical analysis of zebrafish eyes before and after PTU treatment. Immunostaining was conducted on 10-mm-
thick cryosections of PTU-treated and control larvae at 4 dpf with the following first antibodies: (A & A’) anti-zpr1 for cones (red arrowhead), (B & B’)
anti-zpr2 for RPE (red arrowhead), (C & C’) anti-zpr3 for rods (red arrowhead), (D & D’) anti-Islet1 for GCs, ACs, BCs and HCs, (E & E’) anti-acetylated a-
tubulin for the axons of differentiated neurons, (G & G’) anti-PH3 for mitotic cells (red arrowheads) and (H & H’) anti-active caspase3 for apoptotic
cells. (F & F’) MCs were visualized by cryosectioning of a transgenic fish Tg(gfap:GFP)
mi2001 treated with PTU in the same manner. The cell bodies were
visualized by green fluorescence (red arrowhead). All positive signal areas or cell counts were extracted and normalized by retinal area, which was
traced in the channel with DAPI nuclei stain. There are no differences in staining of any markers between the PTU-treated and control groups except
for zpr2, in which the positive signal/ retinal area was larger in the PTU-treated group. All images are transverse sections; the lens is on the left (the
location is indicated by a dotted yellow circle in (B)) and dorsal is up. The approximate retinal cell layers and cell types are indicated in (D) and (F).
Scale bar =50 mm.
doi:10.1371/journal.pone.0040132.g003
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The expression of these two genes in zebrafish larvae has been
shown to increase and decrease respectively after treatment with
exogenous thyroid hormones [39]. The total RNAs for this qPCR
analysis were extracted from the larvae whose eye and body
lengths were measured (Figure 4B) in order to correlate any
morphological changes with the altered thyroid hormone activity.
Three technical replications were conducted. Compared with the
untreated controls, all three thyroid hormones could induce an
increase and a decrease in the expression of TRa and D2
respectively as expected (PTU+TriAc vs. control – TRa: (fold
change [range of fold change]) 10.84 [8.25–14.25], D2: 0.28
[0.20–0.40]; PTU+T3 vs. control – TRa: 2.33 [1.78–3.06], D2:
0.77 [0.58–1.03]; PTU+T4 vs. control – TRa: 6.12 [4.65–8.05],
D2: 0.45 [0.25–0.78]). These results suggest that the thyroid
hormones used in the rescue experiments were effective. It should
be noted that the range of the fold change of D2 in the PTU+T3
group overlaps with one; nonetheless, its positive effect on the
expression level of TRa still supports that the T3 treatment was
effective.
To determine the effect on eye growth by these combined
thyroid hormone and PTU treatments, eye and body lengths were
measured and their ratio calculated from 10 larvae in five
treatment groups at 105 hpf. These larvae were treated with
nothing (control), with PTU only, and with PTU plus TriAc, T3 or
T4 as described above (Figure 4B). All embryos were collected
from the same parents to ensure comparability. An ANOVA
indicates that the chemical treatments had an effect on eye/body
size ratio (F(4, 45) =41.05, p-value =1.8e–14). Specifically, the
eye/body size ratios of the PTU-treated larvae were smaller
compared with the controls (Bonferroni-adjusted p-value =0.048),
while the ratios of PTU+T4 and PTU+T3 treatment groups were
not different from the PTU-treated group (Bonferroni-adjusted p-
values =0.77 & 0.33 respectively). An unexpected finding was that
the eye/body size ratio of the PTU+TriAc treatment group was
smaller than the PTU-treated group (Bonferroni-adjusted p-value
=1.09e–10).
Despite an insignificant p-value in the statistic comparison, the
PTU+T3 group was the only group that apparently had a larger
median eye/body size ratio compared with the PTU-treated group
(Figure 4B). To determine whether this was an artifact in the
experiment or a potential rescue effect by T3, another six
independent experiments were conducted at 3 dpf (The total N for
the control, PTU-treated and PTU+T3 treatment groups in all
experiments was 65). The results from a linear mixed-effects model
indicate that the treatments altered the eye/body size ratio (F(2,
188) =9.03, p-value =2e–04). However, post hoc comparisons
indicate that there was no difference in the ratio between PTU-
treated and PTU+T3 treatment groups (Bonferroni-adjusted p-
value =0.55); and only the PTU-treated group had a reduced
eye/body size ratio compared with the control group (Bonferroni-
adjusted p-value =0.0059). The lack of a clear rescue effect by T3
was not likely caused by an insufficient treatment time, as when
two of these experiments were measured again on day 4, none
showed a difference in the eye/body size ratio between the
PTU+T3 treatment and PTU-treated groups (Bonferroni-adjusted
p-value =0.64). Together, the data suggest that while PTU
treatment suppresses thyroid hormone synthesis, this disruption in
thyroid hormone production is not likely the cause of the specific
reduction of eye size in the PTU-treated larvae.
Only inhibitors of thyroid peroxidase, and not other
types of goitrogens, specifically reduce eye size
PTU inhibits TPO, one of the two molecular targets in the
thyroid hormone synthesis pathway that common goitrogens
would target to [40]. TPO catalyzes the oxidation of iodide in the
thyroid follicle and in turn facilitates the iodination of thyroglob-
ulin [41]. The other molecular target of common goitrogens is
sodium-iodide symporter (NIS) which mediates the first step in the
thyroid hormone synthesis by transporting iodide ions into the
thyroid follicular cells [42,43].
Figure 4. PTU suppresses thyroid hormone production but its specific inhibition on eye growth is not related to a general
suppression of thyroid hormone synthesis. (A) Whole-mount immunostaining against T4 was performed on PTU-treated and control larvae at 4
dpf. In controls, the T4+ thyroid follicles were stained as dark brown spots along the ventral pharyngeal midline. This staining was substantially
diminished or absent in the PTU-treated larvae and in the control without the first antibody. Scale bar =50 mm. (B) A boxplot of eye/body size ratios
from an experiment of thyroid hormones supplements along with PTU treatment. Specifically, 10 larvae collected from the same parents were treated
with nothing (control), PTU, PTU with 0.1 mM TriAc, 10 nM T3 or 30 nM T4. While the T3 supplement seemed to increase the eye/body size ratio of the
PTU-treated larvae, statistical analysis on this and six additional independent experiments indicate that this was not a genuine increase. See text for
details.
doi:10.1371/journal.pone.0040132.g004
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suppression of thyroid hormone synthesis and the specific
reduction of eye size in development, six goitrogens, including 6-
n-propyl-2-thiouracil (PTuracil) [33], methimazole (MM) [33], 2,
3-dihydroxypyridine (DHP) [40,44], resorcinol (RES) [40], potas-
sium perchlorate (KClO4) [33] and potassium thiocyanate
(KSCN) [43] were used to treat developing embryos. These six
chemicals belong to three general classes: 1) inhibitors of TPO
with thiocarbamide (PTuracil & MM), the same functional group
as in PTU, 2) inhibitors of TPO without thiocarbamide (DHP &
RES), and 3) inhibitors of NIS (KSCN and KClO4). Specifically,
0.025% PTuracil, 4 mM MM, 1 mM DHP, 0.5 mM RES, 0.2%
KClO4 and 10 mM KSCN were added into the E3 medium as in
the PTU treatment respectively. Multiple independent replications
were conducted and at least 10 larvae were used in each of the
chemical treatment and control group in each repeat.
The effects of the treatment of these chemicals on thyroid
hormone synthesis were determined by whole-mount immuno-
staining as described above (Figure 5A) and the eye and body
lengths of the larvae measured at 3 or 4 dpf (Figure 5B). Each
individual experiment was analyzed by Wilcoxon rank sum test
and the Holm-adjusted p-values of the same type of treatment
were presented in a heatmap (green: Inhibitor , Control, p-value
,0.001; dark green: Inhibitor , Control, p-value .0.001 &
,0.05; red: Inhibitor . Control, p-value ,0.001; dark red:
Inhibitor . Control, p-value .0.001 & ,0.05; black: no change,
p-value .0.05). In addition, all treatment repeats of the same
chemical at 3 dpf were analyzed by fitting a linear mixed-effects
model as described above. In general, while all chemicals were
effective in reducing the staining of T4+ thyroid follicles
(Figure 5A), the magnitude of treatment effects on eye size
reduction varied. First, the eye/body size ratios of larvae treated
withTPOinhibitors,exceptforPTuracil,weredecreasedcompared
with their control siblings (MM: 90.77% of control, SE =1.15%,
F(1, 76) =172.21, p-value =3.20e–21; DHP: 89.26%, SE =
1.70%, F(1, 56) =222.50, p-value =3.69e–21; RES: 97.4%, SE
=2.08%, F(1,75) =25.37, p-value =3.18e–06;PTuracil: 100.78%,
SE =3.98%, F(1, 76) =3.11, p-value =0.082). Second, the eye
reduction effect induced by TPO inhibitors without thiocarbamide
was relatively specific. In fact, there was no reduction of body
length in larvae treated by DHP (F(1, 56) =0.01, p-value =0.92)
and RES (F(1, 75) =0.79, p-value =0.38). Third, the eye/body
size ratios were generally larger in the larvae treated with the two
NIS inhibitors, KClO4 (101.3% of control, SE =5.95%, F(1, 75)
=6.58, p-value =0.012) and KSCN (103.68%, SE =0.99%, F(1,
56) =28.25, p-value =1.92e–06). This effect was actually caused
by a reduction of body length (KClO4: F(1, 75) =24.09, p-value
=5.21e–06; KSCN: F(1, 56) =41.05, p-value =3.29e–08) but not
eye length (KClO4: F(1, 75) =1.43, p-value =0.24; KSCN: F(1,
56) =1.18, p-value =0.28).
While these chemicals are specific thyroid inhibitors, it is
possible that they mediate their effects on growth by other non-
specific changes, including osmolarity and pH, in the E3 medium.
Thus, osmolarity and pH of these chemicals diluted in E3 were
measured (Table 1). At least two measurements were conducted
with independently prepared chemicals with different water
sources, and three technical replicates were used in each
measurement. For osmolarity measurements, an ANOVA shows
that the addition of chemicals could change the osmolarity of the
resulting solutions (F(7,50) =581.6, p-value ,2.2e–16). The post
hoc analysis indicates that the addition of KClO4, KSCN and MM
increased the osmolarity compared with the control (Bonferroni-
adjusted p-values =3.94e–42, 4.76e–30 and 8.36e–7 respectively)
while the addition of the other chemicals did not (p-values .0.05)
(Table 1). For pH measurements, a two-way ANOVA shows that
there was a main effect of chemical treatments (F(7,32) =111.11, p-
value ,2.2e–16) and water sources (F(1,32) =137.51, p-value
=4.01e–13). Specifically, the addition of KClO4 and KSCN
decreased the pH of the solution (Bonferroni-adjusted p-values:
3.58e–8 and 6.96e–6) while the addition of the other chemicals did
not (p-values .0.05) (Table 1). These results do not support the
possibility that changes in osmolarity and pH would specifically
decrease the eye size in zebrafish larvae because (1) KClO4 and
KSCN solutions increased the eye/body size ratio and did not alter
the absolute eye size, despite having the highest increase and
decrease in osmolarity and pH respectively, (2) the addition of PTU
did not alter the osmolarity or pH of the E3, and (3) TPO inhibitors
donotgenerallychangeosmolarityand pH.Theonlyexceptionwas
MM, which modestly increased the osmolarity of E3.
Since only inhibitors of TPO and not NIS can specifically
reduce eye size in a way that is highly similar to that in the PTU-
treated larvae, the data also argue against the role of a general
suppression of thyroid activity in causing a specific eye size
reduction. Furthermore, the absence of the thiocarbamide
functional group in TPO inhibitors including RES and DHP,
and their effectiveness in reducing eye size without affecting body
size strongly argue for the role of Tpo in PTU-induced eye size
reduction.
Tpo is expressed in the mouse retina
The specific effect of TPO inhibition on eye size suggests that
this effect can be localized in the proximity of the eye rather than
caused by a general suppression of thyroid hormone synthesis.
This led to the hypothesis that there was a Tpo or Tpo-like activity
in the eye region. Since the zebrafish tpo sequence is still partial
and tentative (ZFIN ID: ZDB-GENE-110519-2), the expression of
mouse Tpo was analyzed by in situ hybridization on cryosectioned
mouse embryos at stages E13.5 and P0. These periods cover the
developmental stages when the early-born cell types (GCs, HCs,
ACs and cones) and all retinal cell types can be detected in the
retina respectively [45]. The in situ results show that there was a
strong general expression of Tpo in the mouse embryo including
the retina and lens at E13.5 (Figure 6A). By P0, the expression of
Tpo became localized in several regions in the embryo, including a
relatively specific expression in the retina compared with the
surrounding tissue (Figure 6B). The expression pattern of Tpo
supports a possible localized role in growth regulation by eye-
specific TPO.
Other tyrosinase inhibitors do not inhibit pigmentation
as well as PTU or will have adverse side effects
Since PTU has been widely used as an inhibitor of melanization
for zebrafish research, the identification of its specific effects on eye
size indicates the need for a better alternative. To search for
alternative inhibitors for melanization, five tyrosinase inhibitors
were tested. These include cetylpyridinium chloride (CPC) [46], 2-
mercaptobenzothiazole (MBT) [47], mequinol (MQ) [48], 4-
hydroxybenzyl alcohol (4HBA) [49] and 1-hydroxy-3-phenylurea
(HPU) [50]. CPC and 4HBA are irreversible inhibitors of
tyrosinase and are reported to be more potent than PTU [51],
10 mM MBT has been reported as an equally good inhibitor of
melanization as PTU for zebrafish [47], MQ is a competitive
inhibitor and is commonly used in prescription skin lightener [48],
while HPU has been reported to be more potent than PTU [50]. A
titration series of these chemicals except for MBT was tested, and
the resulting effect on gross morphology and pigment inhibition
observed. The specific concentration ranges tested for these
chemicals are as follows: CPC: nine concentrations between 0.03 –
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e40132Figure 5. The suppression of thyroid hormone synthesis by six goitrogens reveals that PTU suppression on eye growth is related to
inhibition of TPO. (A) The six goitrogens used include two TPO inhibitors with thiocarbamide group: 0.025% PTuracil and 4 mM MM; two TPO
inhibitors without thiocarbamide group: 1mM DHP and 0.5mM RES; and two NIS inhibitors: 0.2% KClO4 and 10mM KSCN. All these chemicals were
used to treat zebrafish embryos in the same way as PTU. Whole-mount immunostaining against T4 was performed at 4 dpf as in Figure 4. In controls,
T4+ thyroid follicles were stained as dark brown spots along the ventral pharyngeal midline. This staining was substantially diminished or absent in
the inhibitors-treated groups and in the control without the first antibody. Scale bar =50 mm. (B) A heatmap that shows the results from multiple
experiments in which the larvae were independently treated with these six goitrogens. These include two TPO inhibitors with thiocarbamide group:
0.025% PTuracil (N of independent experiments =4) and 4 mM MM (N=5); two TPO inhibitors without thiocarbamide group: 1mM DHP (N=4),
0.5mM RES (N=5); and two NIS inhibitors: 0.2% KClO4 (N=4) and 10mM KSCN (N=4). All these chemicals were used to treat zebrafish embryos the
same way as PTU and at least 10 larvae were used in each individual treatment in each replication. The eye and body lengths were measured and the
corresponding eye/body size ratios calculated. The eye and body measurements and their ratios between inhibitors-treated and control larvae were
compared by Wilcoxon rank sum test, and the results were presented in a heatmap as in Figure 1. The color of each box represents the difference in
the means of the parameter and the intensity represents the corresponding Holm-adjusted p-value of each test (green: inhibitor , control, p-value
,0.001; dark green: inhibitor , control, p-value .0.001 & ,0.05, black: inhibitor = control, p-value .0.05; dark red: inhibitor . control, p-value
.0.001 & ,0.05; red: inhibitor . control, p-value ,0.001). The experiments analyzed at 4 dpf are highlighted by asterisks; otherwise they were
analyzed at 3 dpf. A linear mixed-effects model was fitted to analyze the effect of individual inhibitors on the measured parameters at 3 dpf. In
general, three (MM, DHP & RES) out of four TPO inhibitors specifically reduced eye/body size ratio while none of the NIS inhibitors did. These
observations suggest that a general suppression of thyroid hormone synthesis is not the cause of the specific eye size reduction, but a specific
inhibition of TPO or TPO-like activity can reduce eye size.
doi:10.1371/journal.pone.0040132.g005
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4HBA: 15 concentrations between 0.3 – 0.9 mM; HPU: nine
concentrations between 0.05 – 1.5 mM. All these concentration
ranges cover the reported inhibitory concentrations, except for the
range for MQ, which is at least 100 times lower than the standard
formulation in the skin lightener (2% or , 161 mM).
The effect of these chemicals on melanization varied. First, the
embryos treated with all concentrations of CPC died within 24
hours of treatment. Second, the treatments of embryos with
various concentrations of MQ (Figure 7E), 4HBA (Figure 7F) or
HPU (Figure 7G) singly could not completely inhibit melanization,
particularly at the concentrations that would show minimal
abnormalities in development. Only 10 mM MBT (Figure 7D)
could inhibit melanization as effectively as 1X PTU (Figure 7B) as
previously reported. Nonetheless, the eye size of the MBT-treated
larvae was substantially reduced compared with the controls at 3
dpf. In particular, the mean of eye/body size ratios of the treated
larvae was 80.6% of untreated controls (Wilcoxon rank sum test, p-
value =1.08e–5), indicating the eye was relatively smaller in the
treated larvae (Figure 7D). Subsequently, a combination treatment
with several chemicals at suboptimal concentrations including
0.3X PTU (Figure 7C), 0.7 mM HBA (Figure 7F) and 0.8 mM
HPU (Figure 7G) was tested for any potential synergistic effects on
melanization inhibition. However, none of the combinations tested
could completely inhibit melanization either (Figure 7H–J).
Furthermore, it was also noticed that two treatments with
0.7 mM 4HBA changed the morphology of the melanocytes
(Figure 7F & J), indicating that this chemical may also affect
melanocyte development in addition to melanization inhibition.
Interestingly, when the same concentration of 4HBA was added
together with 0.3X PTU, the effect on the melanocytes
morphology diminished (Figure 7H & K). The treatments with
HPU also showed a similar but weaker interaction effect with PTU
as in the case of 4HBA (Figure 7G & I). One possible explanation
Table 1. Properties of the solutions used to treat developing zebrafish larvae.
Chemical
Percentage of
chemical in E3 (%)
Molarity of chemical
in E3 (mM)
Osmolarity of chemical
in E3 ( x x±s) mOsm Kg
21
pH measurements;
water source 1
( x x±s)
pH measurements;
water source 2
( x x±s)
Control (E3 only) - - 11.6361.19 5.6860.04 6.1760.09
PTU + E3 0.003 0.2 11.7561.58 5.6860.03 5.9460.02
PTuracil + E3 0.02 1.175 12.7560.89 5.7560.02 5.9960.08
MM + E3 0.046 4 15.6361.19 5.6360.03 5.6960.06
DHP + E3 0.011 1 12.0060.63 5.6660.01 5.5760.02
RES + E3 0.0055 0.5 11.3360.82 5.6460.01 5.5260.02
KClO4 + E3 0.2 14.435 42.0062.27 5.4360.03 5.7860.01
KSCN + E3 0.0972 10 30.0060.00 5.4960.03 5.3660.04
The osmolarity and pH of the chemicals in E3 were determined. For osmolarity, the measurements are combined from at least two different experiments because there
was no difference between individual experiments (ANOVA, F(1,56) =0.24, p-value =0.62). See text for details. While for pH, the measurements of solutions prepared
with two different sources of water were different (ANOVA, F(1,46) =5.35, p-value =0.025); thus each preparation is presented separately.
doi:10.1371/journal.pone.0040132.t001
Figure 6. Tpo is specifically expressed in developing mouse retinas. In situ hybridization was conducted with a riboprobe specific for Tpo on
20-mm-thick cryosections obtained from mouse embryos at E13.5 (A; transverse section) and P0 (B; coronal section). (A) At E13.5, there was a general
expression of Tpo in the whole embryo. (B) By P0, there was a specific expression of Tpo in the retina (black arrowhead) compared with lens (red
arrowhead) and the surrounding periocular tissue (asterisks). Scale bar =200mm for both (A) and (B).
doi:10.1371/journal.pone.0040132.g006
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site in tyrosinase and PTU is the most effective in binding with the
enzyme, thus in the combination treatment, PTU can effectively
occupy the binding site of the enzyme and alleviate the toxic
effects that may be elicited by the other chemicals. Nonetheless,
these results indicate that PTU remains the most effective
chemical inhibitor for zebrafish melanization with the least side-
effects.
Bleaching is an alternative approach for pigment removal
but will compromise downstream applications
One alternative approach for removing pigment is to bleach
fixed embryos. To determine the extent to which bleaching would
affect the quality of immunostaining, a series of experiments were
conducted on embryos treated with PTU or bleached with 3%
H2O2/1% KOH [52] in different manners (Figure 8A). Two first
antibodies, PH3 and zpr2, were used in this test. For PH3, the
immunostaining signal in the sections of the bleached whole-
mount embryos appeared comparable to the untreated or PTU-
treated samples; however, the signal intensity was compromised if
bleaching was conducted on sections. For zpr2, the signal
background was higher in all samples that were bleached
compared with the PTU-treated samples. Nonetheless, the signal
that was obtained from bleaching the sections after incubation
with the first antibody was the closest to the PTU-treated samples.
Thus, different antigens will likely be affected by bleaching
differently and the bleaching protocol would have to be optimized
in each case. For in situ hybridization, a riboprobe against tubulin,
beta 5 (tubb5) was used (Figure 8B). The staining pattern of the
whole-mount embryo was similar between the two groups;
however, the signal of the bleached embryo was much weaker,
and not all regions with positive signal in the PTU-treated
embryos had discernible signal in the bleached samples. Together,
these results suggest that while bleaching can potentially be an
alternative for downstream investigations, PTU treatment for
melanization inhibition remains the most effective approach.
Discussion
This study has identified a specific effect of PTU treatment on
eye size reduction in zebrafish larvae. The size reduction is not
caused by a change in cell-type, proliferation or apoptotic status of
the retinal cells, but is likely a result of tighter packing of these cells
in the retina and a smaller lens. A chemical screen using different
goitrogens and supplementing PTU-treated larvae with thyroid
hormones have indicated the possibility of a reduction of TPO/
TPO-like activity rather than a general level of thyroid hormone to
be the underlying cause of this PTU-induced effect on eye size
reduction. The specific expression of Tpo in the developing mouse
retina at P0 and a general expression in the lens and retina at
E13.5 have provided strong corroborative evidence that a
localized effect of TPO/ TPO-like activity in the eye region is
potentially responsible for mediating an eye-specific outcome by
PTU treatment.
This is not the first time that PTU treatment has been
demonstrated to have an effect on growth and morphology. For
example, a long-term 0.002% PTU treatment on five species of
young tropical fish over eight weeks can depigment and shorten
the body length (Length of treated fish vs. control,  x x=66.32%,
s=5.66%, species N=5) [12]. In the current study, the body size
has also been reduced by PTU treatment, but the present data
have demonstrated that the eye size is specifically reduced to a
greater extent, indicating a tissue-specificity of the treatment.
Interestingly, Frieders also found that 0.0025% PTU treatment
was too toxic for young fish used in his study [12]. His observations
further suggest that the current standard treatment of zebrafish
embryos with 1X PTU (0.003%) would cause unwanted physio-
logical effects, as indicated by the current study and others as
discussed above. One such effect is the inhibition of thyroid
hormone synthesis. It is not surprising that altered thyroid activity
would affect animal growth including the eye. In fact, a recent
investigation of a rat model of thyroid hormone deficiency has
demonstrated that a suppression of thyroid hormone by chemical
inhibition and surgical thyroidectomy would reduce eye volume,
optic nerve cross-sectional area and thickness of retinal layers [53].
However, the body weight gain is substantially lowered in this
mouse model. Thus, it is unclear whether the morphological
changes in the eye are a general effect of suppressing thyroid
hormone production or there is a specific component to it.
Further, it has been reported that a missense mutation in mouse
Tpo causes hypothyroid dwarfism with a general body size
reduction [54]. Presumably the eye size may be smaller, even
though this was not investigated in that study. While these
observations suggest that a normal thyroid activity contributes to a
proper eye growth, the results of the current study indicate a
possible additional layer of regulation by a TPO/ TPO-like
activity that may specifically act in the proximity of the eye region.
Figure 7. Morphology of zebrafish after treatment with various tyrosinase inhibitors. Different tyrosinase inhibitors, when applied at the
same stage as PTU singly or in combination, suppress pigmentation to a different extent at 3 dpf. The inhibitors and their combinations include: (A)
untreated control, (B) 1X PTU, (C) 0.3X PTU, (D) 10 mM MBT, (E) 0.25 mM MQ, (F) 0.7 mM 4HBA, (G) 0.8 mM HPU, (H) 0.3X PTU +0.7mM 4HBA, (I) 0.3X
PTU +0.8 mM HPU, (J) 0.8 mM HPU +0.7 mM 4HBA and (K) 0.3X PTU +0.8 mM HPU +0.7 mM 4HBA. Scale bar =100 mm.
doi:10.1371/journal.pone.0040132.g007
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and/or lens affect the general eye size? One possibility is through
the modification of the extracellular matrix (ECM). TPO and
similar peroxidases are expressed on cell surface [55]. It has been
demonstrated that many of these enzymes create oxidative
damage to ECM [56]; and a change in the strength and/or
integrity of ECM components has been demonstrated to regulate
eye size. For example, it has been observed in developing chick
that by disrupting collagen formation in the vitreous body and the
inner limiting membrane, the eye will be enlarged by 50% in 4
days [57]; and in a number of syndromic diseases that cause
congenital high myopia, ECM proteins are mutated. The TPO/
TPO-like activity in the developing eye may play a similar role in
disrupting ECM by creating localized oxidative damage and this
in turn allows for growth of eye tissue. Thus, the inhibition of TPO
in the eye by PTU treatment will prohibit the eye from growing in
the normal way and result in a smaller size. This change in eye size
after PTU treatment may have implications in human refractive
errors, in which the shape or size of the eye ball is affected by
genetic, environmental and behavioral factors [58]. It is tempting
to speculate that the mechanism as described above and the other
signal transduction pathways that are altered by PTU-treatment
may play a role in refractive errors, and that the regulation of the
components in these pathways by pharmacological approaches
may alleviate these eye conditions. However, early studies on
PTU-treated [59] and tyr [60] larval eyes have demonstrated that
they are emmetropic starting at 72 hpf and at 7 dpf respectively,
arguing against the relationship between refractive errors and
PTU treatment or pigmentation. Nonetheless, these studies have
only investigated young larval eyes; for example, the oldest PTU-
treated larvae that were used in the original study was 136 hpf and
they were emmetropic [59]. It would be interesting to determine
whether a long-term suboptimal dose of localized PTU treatment
would ultimately induce refractive errors in older fish, or whether
such application of PTU in older fish would alter the morphology
of the eye ball.
PTU has been the most effective chemical inhibitor for
melanization of zebrafish larvae. Our initial search for alterative
inhibitors of tyrosinase was not successful. Among all the chemicals
tested, only MBT is seemingly effective in inhibiting general
melanization as reported [47]. Unfortunately, the treatment with
MBT has specifically reduced the eye size to a much larger extent
than the optimal PTU treatment. Indeed, MBT is also a TPO
inhibitor [61] and can suppress thyroid hormone synthesis [62];
thus, the common inhibition of TPO by PTU and MBT
potentially explains the similarities in the outcomes between these
Figure 8. Performance of immunostaining and in situ hybridization after bleaching. (A) Immunostaining experiments were conducted with
untreated, PTU-treated or bleached embryos at 52 hpf. Two first antibodies, anti-PH3 and zpr2 were used. The typical positive signal is indicated by a
red arrowhead in each case. Scale bar =50 mm. (B) An in situ hybridization experiment with tubb5 using PTU-treated or bleached embryos. These
samples were obtained from a double in situ hybridization experiment with another gene stained in red; thus the samples, especially the whole-
mount embryos, look reddish in general. Scale bar =50 & 100 mm for sectioned and whole-mount samples respectively. All images were acquired
with the same parameters and were not altered during the figure composition to ensure comparability across conditions.
doi:10.1371/journal.pone.0040132.g008
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pigment, it will compromise the efficiency of downstream
investigations. Therefore, the findings from this and similar studies
of PTU’s effect on zebrafish development have highlighted an
urgent need to search for novel chemical inhibitors of melaniza-
tion with fewer side effects.
Materials and Methods
Fish maintenance and embryo collection
Wild-type (WT) zebrafish AB and AB/TL, tyr
tk20/+ (sandy/sdy)
[25] and Tg(gfap:GFP)
mi2001[37] lines were used in this study.
Maintenance, embryo collection, staging and incubation were
performed according to standard procedures [17,63]. The
embryos used for an individual experiment were collected from
the same parents and spawned within a 30-minute interval. All
protocols were approved by the Purdue Animal Care and Use
Committee.
Mouse animals and housing
WT CD1 strain was used for producing embryos for in situ
hybridization. All maintenance and procedures were performed as
described [64]. All experiments were approved by the Animal
Studies Committee at Washington University in St. Louis School
of Medicine.
Chemical Treatment
All chemicals used in this study were purchased from Sigma
unless specified otherwise. They were dissolved in 1X E3 medium
[18] (Table 1) and were used to treat embryos starting at 24 hpf.
The control siblings were incubated in either 1X E3 or 1X E3 with
the carrier of the particular chemical. The culture medium was
changed daily. In some experiments, 1X or 0.3X PTU (Sigma and
Alfa Aesar) was also included to inhibit melanization. The thyroid
inhibitors used in this study were PTuracil, MM, DHP, RES,
KClO4 and KSCN. The thyroid hormones used in this study were
T4, T3 and TriAc. The tyrosinase inhibitors used include PTU,
HPU, 4HBA, CPC, MQ and MBT. A literature review was
conducted to select concentrations of these chemicals that would
inhibit tyrosinase and exhibit least side effects. Then, a titration
series of each chemical was tested to identify the highest possible
concentration that did not induce major morphological abnor-
mality, as judge by the deformation of the body and casualty at 5
dpf. The bioactivity of the thyroid hormones was further
determined by qPCR as described below. The final concentrations
of the thyroid hormones and inhibitors used in the study are as
follows: 0.025% PTuracil, 4mM MM, 1 mM DHP, 0.5 mM RES,
0.2% KClO4, 10mM KSCN, 30 nM T4, 10 nM T3 and 0.1 mM
TriAc. The study of the tyrosinase inhibitors was discussed in the
results section.
Morphological analysis
Fish larvae were positioned in 3% methylcellulose (Sigma).
Images of the eye region and the whole body were acquired by a
SPOT-RT3 colour slider camera (Diagnostic Instruments) mount-
ed on an Olympus SZX16 stereomicroscope. Length and area
measurements were conducted on lateral view images by i-
Solution (IMT i-Solution). Body length was measured from the
anterior tip of the snout to the posterior end of the caudal
peduncle of the body. Eye length was measured from anterior to
posterior of the eye along the longest axis. Eye and body areas
were measured by tracing the boundary of the eye and the whole
body excluding the fins respectively on the lateral images.
Histological and immunohistochemical analyses
Histological analysis on 1-mm-thick plastic sections and immu-
nohistochemistry on 10-mm-thick cryosections were conducted as
described [65,66]. To maximize comparability across different
conditions, only sections with an optic nerve in the eyes on both
sides were used. At least five embryos were collected and analyzed
in each experimental group. Ganglion cells, photoreceptor cells,
inner nuclear cells, and marginal zone cells were counted on both
eyes by i-Solution (IMT i-Solution). Retinal and lens areas were
also measured by tracing the boundary of the corresponding eye
tissues or cell layers (IMT i-Solution). Whole-mount immuno-
staining of T4 was conducted using VECTASTAIN Elite
Universal ABC Kit (Vector lab) [33]. The antibodies used in this
study and their dilutions are as follows: mouse anti-zpr1 (1:200,
ZIRC), mouse anti-zpr2 (1:750, ZIRC), mouse anti-zpr3 (1:200,
ZIRC), mouse anti-Islet1 (1:50, Developmental Studies Hybrid-
oma Bank), mouse anti-acetylated a-tubulin (1:1000, Sigma),
rabbit anti-phospho-Histone H3 (PH3) (1:500, Millipore), rabbit
anti-active caspase3 (1:500, BD Biosciences), rabbit anti-T4
(1:4000; MP Biomedicals), Alexa Fluor 488/555 goat anti-
rabbit/mouse IgG (1:1000, Invitrogen). The resulting sections
were imaged by a SPOT-RT3 camera mounted on an Olympus
BX51 fluorescence compound microscope while the whole-mount
samples were imaged as described in the morphological analysis
section. The images were subsequently merged using Adobe
Photoshop CS3 (Adobe).
In situ hybridization
In situ hybridization of Tpo was conducted on 20-mm-thick
cryosections of mouse embryos at embryonic day 13.5 (E13.5) and
postnatal day 0 (P0) as described [64]. A plasmid containing the
mouse Tpo gene (GenBank Accession Number: BC099421) was
purchased from Thermo Scientific. Linearized DNA template for
in vitro transcription of the riboprobe was generated by PCR, using
M13 primers with an additional T7 site on the forward primer and
T3 on the reverse primer. In situ hybridization of tubb5 in zebrafish
was conducted as described [67].
Bleaching
To investigate the performance of bleaching for downstream
applications including immunostaining and in situ hybridization,
embryos were bleached in 3% H2O2/1% KOH [52] in different
manners. This includes bleaching whole-mount embryos for 20 or
30 minutes after fixation, and bleaching cryosectioned samples
collected on a slide for five minutes before or after incubation with
the first antibody. The samples were then analyzed by regular
protocols for immunostaining and in situ hybridization after being
washed extensively.
Quantitative PCR (qPCR)
Larval collection, total RNAs purification and quality checks,
and reverse transcription were conducted as described [68]. qPCR
was conducted using SYBR Green PCR Master Mix (Applied
Biosystems) on an Applied Biosystems 7300 Real-Time PCR
System according to the manufacturer’s instructions. Primers were
designed using Primer Express Version 3.0 (Applied Biosystems)
with standard parameters. The following primer pairs were used in
this study to amplify D2, TRa and b-actin (b-act): D2-FP: 59-
CATCAGCGGTAAGACCCACAA-39, D2-RP: 59-AAGACC-
GGCAGCTGGCTTATA-39,T R a-FP: 59-CTATGAACAGCA-
CATCCGACAAG-39,T R a-RP: 59-CACACCACACACGGCT-
CATC-39, b-act-FP: 59-TGCTGTTTTCCCCTCCATTG-39.
b-act-RP: 59-GTCCCATGCCAACCATCACT-39.
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pH and osmolarity of chemicals were measured by an Orion 2
Star pH meter (Orion) and an Osmette A Automatic Osmometer
(Precision Systems) respectively.
Statistical analysis and data visualization
All standard descriptive statistics and data analyses were
performed in the R statistical environment (http://www.r-
project.org) version 2.11.1. The analysis of the collected data
was conducted by Wilcoxon rank sum test for two groups and
ANOVA for three or more groups. Multiple hypothesis testing
correction for Wilcoxon rank sum tests was conducted by the
Holm’s method. Post hoc comparisons for ANOVA were conducted
using Bonferroni-corrected t-test. Linear mixed-effects model was
built to delineate the specific effect on eye growth by chemical
treatment, with the experiments conducted on different days
modeled as a random effect [69]. qPCR data were analyzed by the
DDCt method [70] implemented in the ddCt package in
Bioconductor (http://www.bioconductor.org/). The qPCR results
were reported in fold change (2 ˆddCt) and the corresponding range
in 2 ˆ(ddCt 6 SE). Standard error propagation was used to combine
measurement errors of the variables. An alpha level of 0.05 was
used for all statistical tests. Heatmaps were generated using
Multiexperiment Viewer (MeV) (http://www.tm4.org).
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